Search

everythinglearnresearchcommunity

for

Search:↓

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to their safety and ease of use.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Alopecia causes emotional distress, and better psychological support is needed.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Androgenetic alopecia in young males leads to lower self-esteem, increased anxiety, and higher depression risk.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Alopecia areata significantly worsens quality of life in children, causing embarrassment and social issues.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Alopecia areata affects quality of life more in adolescents than adults.

Caregivers of teens with alopecia areata face significant mental and work-related challenges.

COVID-19 may trigger hair loss conditions like alopecia areata.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

There's an urgent need for better treatments for hair loss caused by radiation therapy.

5% topical minoxidil effectively treated a boy's congenital triangular alopecia without side effects.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Alopecia areata negatively affects family life, mental health, and quality of life in young people.

Androgenetic alopecia is more common in male Chinese adolescents and linked to rosacea, but doesn't affect quality of life.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The FDA approved a new Pfizer drug for hair loss in teens.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Minoxidil and spironolactone improve hair density and reduce shedding in girls.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Alopecia areata significantly affects emotional well-being and daily activities, suggesting a need for patient-centered care.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.